Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05957406 · ClinicalTrials.gov registry record · NA

SMART TRENDS Study

A NA study, sponsored by Becton, Dickinson and Company.

Completed
Registry status
NA
Development phase
296
Enrollment target

NCT05957406: Completed NA study, sponsored by Becton, Dickinson and Company.

NCT05957406 is a NA study that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 296 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05957406, a NA study, has completed, sponsored by Becton, Dickinson and Company.

COMPLETED
Registry status
NA
Development phase
296 participants
Enrollment target

Study Summary

A multicenter, interventional, feasibility comparison with historical controls

Primary Outcome

The proportion of HPI Smart Alert prompts displayed resulting in initiation of action within 5 minutes consistent with an intra-operative hemodynamic management algorithm.

Interventions

  • DEVICE Acumen HPI Smart Alerts and Smart Trends Software
  • DEVICE The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff

Trial Details

FieldValue
Enrollment Target 296 participants
Start Date 2023-07-11
Est. Completion 2025-10-27
Phase NA
Becton, Dickinson and Company

33 total trials

What the finished NCT05957406 record still lists

NCT05957406 is an interventional study that assigns participants to a tested intervention. The registered 296 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 2 interventions - of which Acumen HPI Smart Alerts and Smart Trends Software is the first listed.

NCT05957406 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05957406 about?

NCT05957406 is a clinical study titled "SMART TRENDS Study". A multicenter, interventional, feasibility comparison with historical controls

What is the current status of trial NCT05957406?

This trial is currently completed. It is a NA study. The enrollment target is 296 participants. The study started on 2023-07-11. Estimated completion is 2025-10-27.

What interventions are being tested in trial NCT05957406?

The interventions under investigation include: Acumen HPI Smart Alerts and Smart Trends Software (DEVICE), The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff (DEVICE).

Who is sponsoring clinical trial NCT05957406?

This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05957406's enrollment target sits among peer trials

296 373rd of 2000 higher than 1,628 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05563792 · 296 participants · NA

    Options for Pain Management Using Nonpharmacological Strategies

  • NCT06828445 · 296 participants · Phase 1

    Increasing Affordable Fruits and Vegetables for Families With Food Insecurity

  • NCT06920563 · 296 participants · NA

    Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

  • NCT06309160 · 297 participants · NA

    COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05957406, the US trial registry maintained by the National Library of Medicine. NCT05957406 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.